Interventions for reducing inflammation in familial Mediterranean fever
Cochrane Collaboration
Cochrane Database Syst Rev · 2022
Key Findings
- ●10 RCTs with 312 participants
- ●Colchicine may reduce people experiencing attacks
- ●Includes assessment of rilonacept, anakinra, canakinumab
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: pmid-35349164PMID: 35349164